ADRB2 - effectivity medication (pharmacogenetics)

This test is available for the following conditions:

  • Conditions > Pharmacogenetics > Asthma treatment (pharmacogenetics)

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week

Method

  • Targeted analysis of one or more mutations
Remarks
Genetic analysis of the c.46G>A (rs1042713) variant in ADRB2.

OMIM: 600807
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 320

Products Conditions Pharmacogenetics Asthma treatment (pharmacogenetics)
Gene

ADRB2 - effectivity medication (pharmacogenetics)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week
Performing laboratory
Radboudumc
€ 320

ADRB2 - effectivity medication (pharmacogenetics)



€ 320